drugset / Trial / NCT00826020

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

NCT00826020

Phase 2 Completed 72 enrolled University of Nebraska
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if established parenteral nutrition (PN) associated liver disease can be reversed or its progression halted by using a parenteral fat emulsion prepared from fish oil as measured by normalization of serum levels of hepatic enzymes and bilirubin.

Timeline

Start
2009-05-01
Primary completion
2017-10-06
Completion
2017-10-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Omegaven Other / unclassified 1 g/kg Intravenous